1. Home
  2. QTTB vs VNCE Comparison

QTTB vs VNCE Comparison

Compare QTTB & VNCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QTTB
  • VNCE
  • Stock Information
  • Founded
  • QTTB 2015
  • VNCE 2002
  • Country
  • QTTB United States
  • VNCE United States
  • Employees
  • QTTB N/A
  • VNCE N/A
  • Industry
  • QTTB Biotechnology: Pharmaceutical Preparations
  • VNCE Clothing/Shoe/Accessory Stores
  • Sector
  • QTTB Health Care
  • VNCE Consumer Discretionary
  • Exchange
  • QTTB Nasdaq
  • VNCE Nasdaq
  • Market Cap
  • QTTB 23.3M
  • VNCE 20.2M
  • IPO Year
  • QTTB N/A
  • VNCE 2013
  • Fundamental
  • Price
  • QTTB $1.85
  • VNCE $2.70
  • Analyst Decision
  • QTTB Hold
  • VNCE Strong Buy
  • Analyst Count
  • QTTB 8
  • VNCE 4
  • Target Price
  • QTTB $24.00
  • VNCE $4.63
  • AVG Volume (30 Days)
  • QTTB 83.8K
  • VNCE 5.2M
  • Earning Date
  • QTTB 11-06-2025
  • VNCE 09-10-2025
  • Dividend Yield
  • QTTB N/A
  • VNCE N/A
  • EPS Growth
  • QTTB N/A
  • VNCE N/A
  • EPS
  • QTTB N/A
  • VNCE N/A
  • Revenue
  • QTTB N/A
  • VNCE $291,286,000.00
  • Revenue This Year
  • QTTB N/A
  • VNCE $1.93
  • Revenue Next Year
  • QTTB N/A
  • VNCE $4.91
  • P/E Ratio
  • QTTB N/A
  • VNCE N/A
  • Revenue Growth
  • QTTB N/A
  • VNCE N/A
  • 52 Week Low
  • QTTB $1.35
  • VNCE $1.02
  • 52 Week High
  • QTTB $53.17
  • VNCE $6.89
  • Technical
  • Relative Strength Index (RSI)
  • QTTB 50.81
  • VNCE 72.39
  • Support Level
  • QTTB $1.62
  • VNCE $1.47
  • Resistance Level
  • QTTB $2.00
  • VNCE $4.20
  • Average True Range (ATR)
  • QTTB 0.14
  • VNCE 0.22
  • MACD
  • QTTB 0.02
  • VNCE 0.15
  • Stochastic Oscillator
  • QTTB 60.53
  • VNCE 46.97

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.

Share on Social Networks: